A case of primary intraocular lymphoma resistant to methotrexate therapy

Miwa Kanaumi, Hiroshi Yoshikawa, Ko Hei Sonoda, Keijiro Ishikawa, Tatsuro Ishibashi

Research output: Contribution to journalArticlepeer-review


Background: Treatment by methotrexate (MTX) for primary intraocular lymphoma (PIOL) has attracted attention in recent years. Case-report: A 51-year-old woman visited our hospital with binocular vitreous opacity that was unresponsive to therapy with corticosteroids. We diagnosed PIOL by the cytological findings and intraocular IL-10 level. Although her vitreous opacity disappeared by intravitreal MTX injection initially, in the course of repeated injections, MTX gradually became ineffective and subretinal tumor appeared, which did not respond to subsequent high-dose MTX therapy. Finally, by radiation therapy, the tumor cleared and her visual function improved. Conclusion: MTX therapy including high-dose MTX treatment may not be effective against PIOL.

Original languageEnglish
Pages (from-to)411-415
Number of pages5
JournalFolia Japonica de Ophthalmologica Clinica
Issue number5
Publication statusPublished - May 2009

All Science Journal Classification (ASJC) codes

  • Ophthalmology


Dive into the research topics of 'A case of primary intraocular lymphoma resistant to methotrexate therapy'. Together they form a unique fingerprint.

Cite this